As I ate breakfast one morning, I overheard two
oncologists conversing. One complained bitterly, "You know,
Bob, I just don't understand it. We used the same drugs, the
same dosage, the same schedule and the same entry criteria.
Yet I got a 22 percent response rate and you got a 74
percent. That's unheard of for metastatic cancer. How do you
do it?"
His colleague replied, "We're both using Etoposide,
Platinum, Oncovin and Hydroxyurea. You call yours EPOH. I
tell my patients I'm giving them HOPE. As dismal as the
statistics are, I emphasize that we have a chance."
